
Vivoryon Therapeutics
Biopharmaceutical company focused on the development of innovative small molecule drugs.
Market cap
$41.7m
Enterprise value
$32m
Share price
€1.46 VVY.AS
Authorizing premium user...
Biopharmaceutical company focused on the development of innovative small molecule drugs.